An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults.

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults.

Show other versions (1)

There is no parenteral formulation of the neuraminidase inhibitor oseltamivir, the most widely used anti-influenza virus drug. Oseltamivir resistance is an increasing problem. Zanamivir is effective against the most prevalent oseltamivir-resistant influenza viruses. A parenteral formulation of zanam...

Full description

Bibliographic Details
Main Authors:	Pukrittayakamee, S, Jittamala, P, Stepniewska, K, Lindegardh, N, Chueasuwanchai, S, Leowattana, W, Phakdeeraj, A, Permpunpanich, S, Hanpithakpong, W, Pan-Ngum, W, Fukuda, C, Panapipat, S, Singhasivanon, P, White, N, Day, N
Format:	Journal article
Language:	English
Published:	2011

Similar Items

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy thai adults
by: Pukrittayakamee, S, et al.
Published: (2011)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.
by: Jittamala, P, et al.
Published: (2014)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese thai subjects
by: Jittamala, P, et al.
Published: (2014)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks.
by: Anekthananon, T, et al.
Published: (2013)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in thai health workers: A randomized, double-blind, placebo-controlled safety trial over 16 weeks. [J Antimicrob Chemother 68, (2013) 697-707]
by: Anekthananon, T, et al.
Published: (2013)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
by: Chairat, K, et al.
Published: (2016)

Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
by: Hanboonkunupakarn, B, et al.
Published: (2014)

Pharmacokinetics of high-dose oseltamivir in healthy volunteers.
by: Wattanagoon, Y, et al.
Published: (2009)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.
by: Lindegårdh, N, et al.
Published: (2007)

Quantification of the anti-influenza drug zanamivir in plasma using high-throughput HILIC-MS/MS.
by: Lindegardh, N, et al.
Published: (2011)

Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers.
by: Instiaty, I, et al.
Published: (2013)

Development and validation of a high-throughput zwitterionic hydrophilic interaction liquid chromatography solid-phase extraction-liquid chromatography-tandem mass spectrometry method for determination of the anti-influenza drug peramivir in plasma.
by: Lindegardh, N, et al.
Published: (2008)

Importance of collection tube during clinical studies of oseltamivir.
by: Lindegardh, N, et al.
Published: (2007)

Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterases.
by: Lindegardh, N, et al.
Published: (2006)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Treated with Nebulized Zanamivir
by: Liviana Da Dalt, et al.
Published: (2010-11-01)

Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.
by: Jittamala, P, et al.
Published: (2015)

Study of oseltamivir and zanamivir resistance-related mutations in influenza viruses isolated from wild mallards in Sweden.
by: Goran Orozovic, et al.
Published: (2014-01-01)

Eficacia del tratamiento y la profilaxis de la gripe con oseltamivir o zanamivir
by: Francisco Peper
Published: (2014-07-01)

A liquid chromatographic-tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma.
by: Hanpithakpong, W, et al.
Published: (2009)

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir
by: Itagaki Tsutomu, et al.
Published: (2010-03-01)

Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial.
by: Xavier Duval, et al.
Published: (2010-11-01)

Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birds.
by: Goran Orozovic, et al.
Published: (2011-01-01)

Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial
by: Min Li, et al.
Published: (2020-11-01)

Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation
by: P Tappenden, et al.
Published: (2008-02-01)

Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial.
by: Xavier Duval, et al.
Published: (2010-12-01)

A liquid chromatographic-tandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma.
by: Hanpithakpong, W, et al.
Published: (2008)

Quantification of dihydroartemisinin, artesunate and artemisinin in human blood: overcoming the technical challenge of protecting the peroxide bridge.
by: Lindegardh, N, et al.
Published: (2011)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
by: Seo, S, et al.
Published: (2013)

Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs
by: Chairat, K, et al.
Published: (2018)

Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria.
by: Pukrittayakamee, S, et al.
Published: (2008)

Orally formulated artemisinin in healthy fasting Vietnamese male subjects: a randomized, four-sequence, open-label, pharmacokinetic crossover study.
by: Hien, T, et al.
Published: (2011)

Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.
by: Taylor, W, et al.
Published: (2008)

Pharmacokinetic interactions between primaquine and chloroquine.
by: Pukrittayakamee, S, et al.
Published: (2014)

Different Inhibitory Potencies of Oseltamivir Carboxylate, Zanamivir, and Several Tannins on Bacterial and Viral Neuraminidases as Assessed in a Cell-Free Fluorescence-Based Enzyme Inhibition Assay
by: Stefanie Quosdorf, et al.
Published: (2017-11-01)

Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.
by: Takeuchi, R, et al.
Published: (2010)

Some novel insights into the binding of oseltamivir and zanamivir to H5N1 and N9 influenza virus neuraminidases:a homology modeling and flexible docking study
by: MARIJA L. MIHAJLOVIC, et al.
Published: (2009-01-01)

Some novel insights into the binding of oseltamivir and zanamivir to H5N1 and N9 influenza virus neuraminidases: A homology modeling and flexible docking study
by: Mihajlović Marija L., et al.
Published: (2009-01-01)

Major pitfalls in the measurement of artemisinin derivatives in plasma in clinical studies.
by: Lindegardh, N, et al.
Published: (2008)

Sequential open-label study of the safety, tolerability, and pharmacokinetic interactions between dihydroartemisinin-piperaquine and mefloquine in healthy Thai adults
by: Hanboonkunupakarn, B, et al.
Published: (2019)

Intravenous zanamivir for influenza myocarditis and enteral malabsorption
by: Fritz-Patrick Jahns, et al.
Published: (2018-12-01)